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Summary: Proportions of collagen type I and type III were investigated in different tissues (kidney, liver, heart
muscle, esophagus, lung and skin) in a single case of malignant systemic scleroderma. The proportion of collagen
type HI was higher than in healthy controls. Similarly, an increase in the proportion of collagen type III was shown
in tissues affected by other inflammatory diseases. Further the authors suggest that the increase in total kidney col-
lagen, especially type III, has important consequences for kidney function; in the described case it had the critical
influence on the fatal course of the disease, and the patient died from uremia.
Kollagen-Heterogenität bei systemischer Sklerodermie und anderen Erkrankungen
Zusammenfassung: Die Anteile von Kollagen Typ I und Typ III wurden in verschiedenen Geweben (Niere, Leber,
Myokard, Oesophagus, Lunge und Haut) bei einem Fäll von maligner systemischer Sklerodermie untersucht. Generell
wurde im Vergleich zu Gesunden eine Zunahme des Anteils von Kollagen Typ III festgestellt. Gleichermaßen eine Zu-
nahme des Anteils von Kollagen Typ III findet in Geweben bei anderen entzündlichen Erkrankungen statt. Die
Autoren weisen daraufhin, daß die Zunahme des Gesamt-Kollagen, insbesondere des Kollagen Typ III, in der Niere
von Bedeutung für die Funktion der Niere ist und daß dies im beschriebenen Fall einen kritischen Einfluß auf den
Verlauf der Erkrankung hatte, da der Patient an Uraemie verstarb.
Introduction
Current knowledge of systemic scleroderma extends
mainly to the descriptive phase, and our understanding
of the disease remains superficial. The skin and sub-
cutaneous elements are not exclusively affected, but
the process may be widespread and involve virtually all
the tissues of the body. The prognosis of life in the
patient with systemic scleroderma depends on the
presence and degree of visceral involvement. The most
critical organ involvement^ which can be fatal in ä
matter of weeks or several months, are renal or
cardiopulmpnary. On the other hand esophageal hypo-
mobility is the most common visceral manifestation of
scleroderma, and it often appears early. Histologie
examinations of systemic scleroderma lesions show alter-
ation of collagen fibers (1). On the other hand the results
of different authors (2,3) suggest increased collagen bio-
synthesis in a number of patients with systemic sclero-
derma.
Recent advances in collagen chemistry have made
possible the detailed characterization of the insoluble
ifraction. These studies have led to the discovery of
collagen heterogeneity. The more abundant type I
collagen of molecular composition ( ( ))2 2 is
present, together with another genetically distinct
collagen type III of molecular composition (a1(III))3
in interstitial tissues. Other genetically distinct
collagens are: collagens type IV of composition
(ai(IV))3, and the newly discovered type V from blood
vessels, composed of chains oA and aB (4). The occur-
rence of collagen polymorphism has been identified in
different tissues such as skin, aorta, liver, lung, kidney,
synovial membrane, peripheral nerve. The content of
collagen type II in the loose connective tissue changes in
certain physiological and pathological states.
In this report we present data suggesting an increase in
.the quantity of collagen type III in different tissues
0340-076X/79/0017-0495S02.00
© by Walter de Gruyter & Co. · Berlin · New York
496 Adam, Dostal and Deyl: Collagen heterogeneity in systemic scleroderma and other diseases
involved with systemic scleroderma, as well as other
sources of inflammatory diseases.
Material and Methods
Samples of tissues
One case of malignant systemic scleroderma was studied. This
was a 42 year-old female, in which only six months elapsed
between the onset of symptoms and death. In spite of high
doses of corticosteroids, the situation of the patient rapidly
became worse; urea nitrogen in the blood increased to
119 mg/dl, severe chest pains appeared, extrasystolae were
observed in ECG and finally anuria occured before exitus.
Ischemic necroses of renal cortex, serofibrinous pericarditis
and esophagal erosions, besides others, were found at
necropsy.
For comparison skin biopsy was taken from a patient (48
years old) with systemic scleroderma, which was taking a
normal course. Cases of bronchopneumonia and a case of
liver cirrhosis were also analyzed, in order to study the
differences in the respective organs. Further, the composition
of collagen was investigated in rheumatoid nodule and in
rheumatoid synovial tissue.
Samples of organs under investigation were obtained at
necropsy from 3 healthy individuals (46, 53 and 62 years
old) that died during traffic accidents. The diagnoses of
scleroderma and of rheumatoid arthritis were done according
to the A.R.A. criteria (5).
Collagen preparations
Collagens type I and III were isolated by pepsin digestion
according to Fujji & Kühn (6) and the values were calculated
from the hydroxyproline content using correction factors
with respect to different hydroxyproline concentration in both
collagen types (7.46 for type I and 5.5 for type III).
Separation techniques
Polyacrylamide gel electrophoresis was performed by the
modified method of Stark & Kühn (7), using 0-alanine buffer
pH 4.3. The gels were stained with Amido Black 10 B and
then evaluated at 680 nm in a Perkin Elmer UV Spectrophoto-
meter Model 402 equipped with a gel scanning accessory.
CM cellulose chromatography (CM cellulose 52 Whatman) was
by the original method ofPiez et al. (8). The column was
1.6 X 6 cm thermostated at 40°C with a flow rate 72 ml/h.
A linear gradient was prepared from two 120 ml quantities of
appropriate buffers. The effluent was monitored on a UV
spectrophotometer (Perkin Elmer Model 402) using an ultramicro
flow-through cell at 230 nm.
Other analyses
Hydroxyproline was assayed according to Stegeman (9).
Results and Discussion
Solubility criteria have served for years äs the only
indicator of differences in collagen from different
sources. This included differences between normal
tissues, and differences caused by pathological
conditions. With the discovery of different collagen
types, the question of the relative proportions of these
became pertinent.
The main tissues involved in malignant systemic
scleroderma were therefore investigated with respect
to the content of collagen type III. Normal tissues as
well as tissues affected with various diseases served as
controls. The identity and purity of isolated collagen
type III were proved in all samples by carboxymethyl
cellulose chromatography as well as by polyaciylamide
gel electrophoresis without and with dithiothreitol
pretreatment (fig. 1, 2). Electrophoretic runs revealed the
expected increase of the -band after dithiothreitol treat-
ment. The Chromatographie and electrophoretic profiles
were in all cases rather similar, and in the figures
collagen type III from systemic scleroderma malignant
skin is shown as an example.
The data reported here are valid of course for the pepsin
solubilized fraction of insoluble collagen, as this solubili-
zatiori is incomplete in old tissues. According to the
results of the methods used the possibility cannot be
excluded that small amounts of collagen type I may be
present in the fraction precipitated with 1.7 mol/1
NaCl; this would be unlikely, however, to have a
pronounced effect upon the results. On the other hand
basement membrane collagen (type IV) has a precipi-
tation profile similar to that of type III (10), and this
might influence the presented data to a greater extent
in liver and kidney samples. In healthy tissues the
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Fig. 1. CM cellulose chromatography of collagen type I ( ) and collagen type III (- ) Column 1.6 X 6 cm therinostated at
40 °C, flow rate 72 ml/h; linear gradient from two 120 ml quantities of appropriate buffers (8).
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Fig. 2. Densitometric tracing of polyacrylamide gel electro-
phoresis.
a) without dithiothreitol;
b) after dithiothreitol pretreatment of collagen type 111.
lowest amounts of collagen type HI occurred in synovial
tissue and skin (about 20%), while parenchymatous
organs, heart muscle and esophagus constitute about
one third of pepsin solubilized collagen (tab. 1). It is
to be expected that under normal conditions the amount
of collagen type III will vary with age, as shown for skin
by Epstein (11) and Deyl & Adam (12). Furthermore,
from the table, it is also evident that collagen type III is
increased in inflammed tissues, i.e. in tissues involved
with systemic sclerosis as well as with rheumatoid
arthritis and bronchopneumonia.
Organ function, especially in parenchymatous organs,
is affected not only by the concentration of single
collagen types, but also by the total collagen content,
which is also increased in diseased tissues. We suggest
that this fact is very important for the function of kidney.
In the case reported here, collagen exerted an indis-
putably critical influence on the fatal course of the
disease, and the patient died from uremia. As expected
from the clinical course and pathological picture,
collagen metabolism was also affected in other visceral
organs (liver, lung, heart muscle, esophagus).
Of particular interest are collagen changes in liver, where
in cirrhosis the amount of collagen type III was lower than
in healthy controls. Fleischmajer et al. (13) reported that
in sclerodermous skin collagen type III is increased mainly
in the lower dermis and in subcutaneous tissue.
In general, synthesis of collagen type III predominates in
newly formed tissues. Gay et al. (14) showed that a single
cell is capable of synthesizing both collagen types I and
III. In other words it appears that there is a certain
category of pathological situations in which the
mechanisms determining the type of collagen to be
synthesized by a certain population of fibroblasts, or the
mechanisms of collagen degradation, are altered. With
respect to scleroderma, the protein synthesizing
mechanisms must be considered, since it has been
shown by Brady (15) that in a number of organs in this
disease, there is little or no collagenolytic activity.
The actual proportions between individual collagen
types, as well as the total amount of collagen, are, of
course, influenced by the course of the pathological
process. Variations are found in the solubility of skin
collagen in scleroderma, and increased as well as
decreased collagen concentrations can be found in the
soluble fractions (16, 17, 18). In the active stage of
scleroderma an increase of collagen biosynthesis has
been definitely proved (19), while decreased values have
been described in extreme fibrosis.
It is now apparent, that in addition to being the major
structural protein, stabilizing body organs by the mecha-
nical strength of its fibers, collagen is also essential for
cytodifferentiation, in which it plays a key role. Colla-
gen metabolism and its disturbances are, from this point
of view, of crucial importance.
Tab. 1. Collagen type III content from insoluble pepsin-treated collagen in various tissues (in mg/g of total solubilized collagen).
Investigated tissue
Skin
Esophagus
Heart muscle
Liver
Lung
Kidney
Synovial tissue
Normal
46
221
342
325
391
302
351
24 years old
53 62
years old
208
332
337
379
288
340
191
331
301
382
294
312
204
Diseased
SSM+
Systemic scleroderma (48 years old)
SSM
SSM
SSM
Cirrhosis, late stage (62 years old)
SSM
Bronchopneumonia 1 st case (68 years old)
2nd case (54 years old)
SSM
Rheumatoid arthritis (35 years old)
Rheumatoid nodule (44 years old)
411
362
444
408
458
302
418
467
380
430
318
438
+SSM - systemic scleroderma malignant (42 years old)
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